We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+35.16%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$20.1B
AUM Growth
+$3.92B
Cap. Flow
-$253M
Cap. Flow %
-1.26%
Top 10 Hldgs %
28.27%
Holding
390
New
38
Increased
100
Reduced
186
Closed
43

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$108M
2
ASAN icon
Asana
ASAN
+$77.4M
3
PINS icon
Pinterest
PINS
+$73.2M
4
ONEM
1Life Healthcare
ONEM
+$65.8M
5
TWLO icon
Twilio
TWLO
+$57.3M

Top Sells

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$204M
2
RNG icon
RingCentral
RNG
+$139M
3
TSLA icon
Tesla
TSLA
+$114M
4
DXCM icon
DexCom
DXCM
+$70M
5
ZM icon
Zoom
ZM
+$64.7M

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 23.77%
3 Consumer Discretionary 20.21%
4 Communication Services 12.3%
5 Miscellaneous 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
301
Allogene Therapeutics
ALLO
$615M
$1K ﹤0.01%
41
-61,775
-100% -$2.01M
APPN icon
302
Appian
APPN
$2.74B
– –
-24,709
Closed -$1.6M
AXGN icon
303
Axogen
AXGN
$2.35B
– –
-24,713
Closed -$287K
BCRX icon
304
BioCryst Pharmaceuticals
BCRX
$2.1B
– –
-592,200
Closed -$2.03M
KNTK icon
305
Kinetik
KNTK
$4.4B
– –
-115,858
Closed -$644K
KRUS icon
306
Kura Sushi USA
KRUS
$496M
– –
-2,973
Closed -$39K
LEGN icon
307
Legend Biotech
LEGN
$3.6B
– –
-16,768
Closed -$518K
LITE icon
308
Lumentum
LITE
$74.9B
– –
-10,096
Closed -$759K
MEC icon
309
Mayville Engineering Co
MEC
$487M
– –
-55,860
Closed -$513K
OPEN icon
310
Opendoor
OPEN
$2.71B
– –
-793,077
Closed -$14.6M
PEN icon
311
Penumbra
PEN
$12.6B
– –
-2,133
Closed -$415K
PLTR icon
312
Palantir
PLTR
$416B
– –
-18,987
Closed -$180K
SBLK icon
313
Star Bulk Carriers
SBLK
$3.44B
– –
-10,000
Closed -$69K
SINT icon
314
SiNtx Technologies
SINT
$12M
– –
0
– –
SLQT icon
315
SelectQuote
SLQT
$88.3M
– –
-4,003
Closed -$81K
TWST icon
316
Twist Bioscience
TWST
$8.93B
– –
-12,808
Closed -$973K
VICR icon
317
Vicor
VICR
$8.52B
– –
-68,039
Closed -$5.29M
VIR icon
318
Vir Biotechnology
VIR
$1.8B
– –
-54,034
Closed -$1.85M
WYNN icon
319
Wynn Resorts
WYNN
$9.04B
– –
-1,533
Closed -$110K
DM
320
DELISTED
Desktop Metal, Inc.
DM
– –
-1,263
Closed -$136K
AMRS
321
DELISTED
Amyris Inc.
AMRS
– –
-51,369
Closed -$150K
APTO
322
DELISTED
Aptose Biosciences, Inc.
APTO
– –
0
– -$1K
AUD
323
DELISTED
Audacy, Inc.
AUD
– –
-26,326
Closed -$42K
MYOV
324
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-184,128
Closed -$2.59M
QTNT
325
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-2,770
Closed -$570K
10 11 12
13
14

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Gilder Gagnon Howe & Co held 390 positions worth $20.1B, up 24% from $16.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2020 filing shows 38 new, 100 increased, 186 reduced and 43 closed positions. Its largest new stake was Asana: 3,026,048 shares worth $89.4M. The largest sale was Livongo Health, Inc. Common Stock, an estimated $204M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2020 buy was Asana: 3,026,048 shares worth $89.4M.
  • Gilder Gagnon Howe & Co added most to Teladoc Health in Q4 2020, an estimated $108M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2020 reduction was RingCentral, cutting an estimated $139M.
  • Gilder Gagnon Howe & Co fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $204M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 28% of its $20.1B portfolio in Q4 2020.
  • Gilder Gagnon Howe & Co opened 38 new positions and closed 43 in Q4 2020.
  • Gilder Gagnon Howe & Co's portfolio value rose 24% quarter-over-quarter to $20.1B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.